DXC Technology Co: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 4, 2021 and accepted by EDGAR at Nov 3, 2021, 20:23 ET.
Management's discussion and analysis
As filed, 52,226 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Introduction
The purpose of the Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is to present information that management believes is relevant to an assessment and understanding of our results of operations and cash flows for the second quarter and first six months of fiscal 2022 and our financial condition as of September 30, 2021. The MD&A is provided as a supplement to, and should be read in conjunction with, our financial statements and accompanying notes.
The MD&A is organized in the following sections:
- Background
- Results of Operations
- Liquidity and Capital Resources
- Off-Balance Sheet Arrangements
- Contractual Obligations
- Critical Accounting Policies and Estimates
The following discussion includes a comparison of our results of operations and liquidity and capital resources for the second quarters and first six months of fiscal 2022 and fiscal 2021.
Background
DXC Technology helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world’s largest companies and public sector organizations trust DXC to deploy services across the Enterprise Technology Stack to drive new levels of performance, competitiveness, and customer experience.
We generate revenue by offering a wide range of information technology services and solutions primarily in North America, Europe, Asia, and Australia. We operate through two segments: Global Business Services (“GBS”) and Global Infrastructure Services (“GIS”). We market and sell our services directly to customers through our direct sales offices around the world. Our customers include commercial businesses of many sizes and in many industries and public sector enterprises.
Results of Operations
The following table sets forth certain financial data for the second quarters and first six months of fiscal 2022 and fiscal 2021:
(In millions, except per-share amounts)
| Three Months Ended September 30, 2021 | September 30, 2020 | Six Months Ended September 30, 2021 | September 30, 2020 | |
|---|---|---|---|---|
| Revenues | $4,027 | $4,554 | $8,168 | $9,056 |
| (Loss) income, before income taxes | (248) | (306) | 176 | (531) |
| Income tax (benefit) expense | (61) | (60) | 81 | (86) |
| Net (loss) income | $(187) | $(246) | $95 | $(445) |
| Diluted (loss) earnings per share | $(0.74) | $(0.96) | $0.35 | $(1.77) |
Fiscal 2022 Second Quarter Highlights
Financial highlights for the second quarter and first six months of fiscal 2022 include the following:
- Revenues for the second quarter and first six months of fiscal 2022 were $4.0 billion and $8.2 billion, respectively, a decrease of 11.6% and 9.8%, respectively, as compared to the second quarter and first six months of fiscal 2021. The decrease was primarily due to the dispositions of the HPS business and other insignificant businesses during the first quarter of fiscal 2022 and the HHS business during the third quarter of fiscal 2021. Project completions and project terminations also contributed to the decrease in revenues. The decrease in revenues was partially offset by increased pass-through revenue associated with the resale of hardware and software and additional services provided to new and existing customers.
- Net loss and diluted loss per share for the second quarter of fiscal 2022 were $(187) million and $(0.74), respectively. Net loss decreased by $59 million during the second quarter of fiscal 2022 as compared to the same period of prior fiscal year. The decrease was primarily due to cost optimization realized in the current period, lower costs after the dispositions of the HPS and HHS businesses, and lower transaction, separation and integration-related costs partially offset by a reduction in revenue in the current period and higher debt extinguishment costs. Net loss included the cumulative impact of certain items of $420 million, reflecting restructuring costs, transaction, separation and integration-related costs, amortization of acquired intangible assets, impairment losses, and debt extinguishment costs. This compares with net loss and diluted loss per share of $(246) million and $(0.96), respectively, for the second quarter of fiscal 2021.
- Net income and diluted earnings per share for the first six months of fiscal 2022 were $95 million and $0.35, respectively. Net income increased by $540 million during the first six months of fiscal 2022 as compared to the same period of prior fiscal year. The increase was primarily due to cost optimization realized in the current period, gain on disposition of the HPS business, lower costs after the dispositions of the HPS and HHS businesses and lower transaction, separation and integration-related costs partially offset by a reduction in revenue in the current period and higher debt extinguishment costs. Net income included the cumulative impact of certain items of $360 million, reflecting restructuring costs, transaction, separation and integration-related costs, amortization of acquired intangible assets, gains on dispositions, impairment losses, debt extinguishment costs, and a tax adjustment. This compares with net loss and diluted loss per share of $(445) million and $(1.77), respectively, for the first six months of fiscal 2021.
- Our cash and cash equivalents were $2.7 billion as of September 30, 2021.
- We generated $534 million of cash from operations during the first six months of fiscal 2022, as compared to $591 million during the first six months of fiscal 2021.
Revenues
During the second quarter and first six months of fiscal 2022 and fiscal 2021, the distribution of our revenues across geographies was as follows:
(in millions)
| Three Months Ended September 30, 2021 | September 30, 2020 | Change | Percentage Change | |
|---|---|---|---|---|
| GBS | $1,873 | $2,242 | $(369) | (16.5)% |
| GIS | 2,154 | 2,312 | (158) | (6.8)% |
| Total Revenues | $4,027 | $4,554 | $(527) | (11.6)% |
(in millions)
| Six Months Ended September 30, 2021 | September 30, 2020 | Change | Percentage Change | |
|---|---|---|---|---|
| GBS | $3,760 | $4,416 | $(656) | (14.9)% |
| GIS | 4,408 | 4,640 | (232) | (5.0)% |
| Total Revenues | $8,168 | $9,056 | $(888) | (9.8)% |
The decrease in revenues for the second quarter and first six months of fiscal 2022, compared with fiscal 2021 of the same periods, reflects the disposition of the HHS business during the third quarter of fiscal 2021, in addition to dispositions of the HPS business and other insignificant businesses during the first quarter of fiscal 2022. Project completions and project terminations also contributed to the decrease in revenues. The decrease in revenues was partially offset by increased pass-through revenue associated with the resale of hardware and software and additional services provided to new and existing customers. Revenues for the second quarter and first six months of fiscal 2022 included an favorable foreign currency exchange rate impacts of 1.4% and 3.6%, respectively, primarily driven by the weakening of the U.S. dollar against the British Pound, Canadian Dollar, and Australian Dollar.
For the discussion of risks associated with our foreign operations, see Part 1, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.
As a global company, approximately 70% of our revenues for the first six months of fiscal 2022 were earned internationally. As a result, the comparison of revenues denominated in currencies other than the U.S. dollar, from period to period, is impacted by fluctuations in foreign currency exchange rates. Constant currency revenues are a non-GAAP measure calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This information is consistent with how management views our revenues and evaluates our operating performance and trends. The table below summarizes our constant currency revenues:
(in millions)
| Three Months Ended Constant Currency September 30, 2021 | September 30, 2020 | Change | Percentage Change | |
|---|---|---|---|---|
| GBS | $1,851 | $2,242 | $(391) | (17.4)% |
| GIS | 2,110 | 2,312 | (202) | (8.7)% |
| Total | $3,961 | $4,554 | $(593) | (13.0)% |
(in millions)
| Six Months Ended Constant Currency September 30, 2021 | September 30, 2020 | Change | Percentage Change | |
|---|---|---|---|---|
| GBS | $3,635 | $4,416 | $(781) | (17.7)% |
| GIS | 4,210 | 4,640 | (430) | (9.3)% |
| Total | $7,845 | $9,056 | $(1,211) | (13.4)% |
Global Business Services
Our GBS revenues were $1.9 billion in the second quarter and $3.8 billion in the first six months of fiscal 2022, a decrease of 16.5% and 14.9%, respectively, compared to the same periods in fiscal 2021. GBS revenue in constant currency decreased by 17.4% and 17.7% in the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods in fiscal 2021. The decrease in GBS revenues for the second quarter and first six months of fiscal 2022 was primarily due to the disposition of the HHS business during the third quarter of fiscal 2021, the disposition of the HPS business at the beginning of the first quarter of fiscal 2022, and project completions. The decrease in GBS revenues was partially offset by additional services provided to existing customers.
For the second quarter and first six months of fiscal 2022, GBS contract awards were $1.7 billion and $4.1 billion, respectively, as compared to $2.4 billion and $5.9 billion in the corresponding periods of fiscal 2021.
Global Infrastructure Services
Our GIS revenues were $2.2 billion in the second quarter and $4.4 billion in the first six months of fiscal 2022, a decrease of 6.8% and 5.0%, respectively, compared to the same periods in fiscal 2021. GIS revenue in constant currency decreased by 8.7% and 9.3% in the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods in fiscal 2021. The decrease in GIS revenues for the second quarter and first six months of fiscal 2022 was primarily due to project completions, project terminations, a decrease in run-rate project volumes, and decreases due to the dispositions of the HHS business and other insignificant businesses. The decrease in GIS revenues was partially offset by additional services provided to new and existing customers.
For the second quarter and first six months of fiscal 2022, GIS contract awards were $2.0 billion and $4.2 billion, respectively, as compared to $2.5 billion and $4.3 billion in the corresponding periods of fiscal 2021.
Costs and Expenses
Our total costs and expenses are shown in the tables below:
(in millions)
| Three Months Ended Amount September 30, 2021 | September 30, 2020 | Percentage of Revenues September 30, 2021 | September 30, 2020 | Percentage Point Change | |
|---|---|---|---|---|---|
| Costs of services (excludes depreciation and amortization and restructuring costs) | $3,088 | $3,563 | 76.7% | 78.3% | (1.6) |
| Selling, general and administrative (excludes depreciation and amortization and restructuring costs) | 370 | 539 | 9.2 | 11.8 | (2.6) |
| Depreciation and amortization | 448 | 525 | 11.1 | 11.5 | (0.4) |
| Restructuring costs | 145 | 265 | 3.6 | 5.8 | (2.2) |
| Interest expense | 61 | 96 | 1.5 | 2.1 | (0.6) |
| Interest income | (16) | (25) | (0.4) | (0.5) | 0.1 |
| Debt extinguishment costs | 281 | — | 7.0 | — | 7.0 |
| Other income, net | (102) | (103) | (2.5) | (2.3) | (0.2) |
| Total Costs and Expenses | $4,275 | $4,860 | 106.2% | 106.7% | (0.5) |
(in millions)
| Six Months Ended Amount September 30, 2021 | September 30, 2020 | Percentage of Revenues September 30, 2021 | September 30, 2020 | Percentage Point Change | |
|---|---|---|---|---|---|
| Costs of services (excludes depreciation and amortization and restructuring costs) | $6,343 | $7,192 | 77.5% | 79.5% | (2.0) |
| Selling, general and administrative (excludes depreciation and amortization and restructuring costs) | 753 | 1,078 | 9.2 | 11.9 | (2.7) |
| Depreciation and amortization | 870 | 1,017 | 10.7 | 11.2 | (0.5) |
| Restructuring costs | 212 | 337 | 2.6 | 3.7 | (1.1) |
| Interest expense | 123 | 202 | 1.5 | 2.2 | (0.7) |
| Interest income | (36) | (48) | (0.4) | (0.5) | 0.1 |
| Debt extinguishment costs | 309 | — | 3.8 | — | 3.8 |
| Gain on disposition of businesses | (377) | — | (4.6) | — | (4.6) |
| Other income, net | (205) | (191) | (2.5) | (2.1) | (0.4) |
| Total Costs and Expenses | $7,992 | $9,587 | 97.8% | 105.9% | (8.1) |
Total costs and expenses as a percentage of revenue decreased by 0.5 and 8.1 percentage points during the second quarter and first six months of fiscal 2022, respectively. The percentage point decreases primarily reflect operating cost reductions exceeding associated declines in revenue compared to the same period in the prior fiscal year. Gains on dispositions during the first quarter of fiscal 2022 also contributed to the percentage point decrease during the first six months of fiscal 2022. The decreases were partially offset by higher debt extinguishment costs incurred during the second quarter and first six months of fiscal 2022.
Costs of Services
Costs of services, excluding depreciation and amortization and restructuring costs (“COS”), was $3.1 billion and $6.3 billion for the second quarter and first six months of fiscal 2022, respectively. COS decreased by $475 million and $849 million during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. The decreases were primarily due to cost optimization savings realized during fiscal 2022 and reduced costs resulting from the dispositions of the HPS business during the first quarter of fiscal 2022 and the HHS business during the third quarter of fiscal 2021. COS as a percentage of revenue decreased by 1.6 and 2.0 points, respectively, as compared to the same periods of the prior fiscal year. These point decreases were primarily driven by cost reductions exceeding the associated decline in revenue compared to the same period in the prior fiscal year.
Selling, General and Administrative
Selling, general and administrative expense, excluding depreciation and amortization and restructuring costs (“SG&A”), was $370 million and $753 million for the second quarter and first six months of fiscal 2022, respectively. SG&A decreased by $169 million and $325 million during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. The decreases were primarily driven by lower transaction, separation and integration-related costs, cost optimization savings realized during fiscal 2022, and reduced costs resulting from the dispositions of the HPS business during the first quarter of fiscal 2022 and the HHS business during the third quarter of fiscal 2021.
Transaction, separation and integration-related costs of $3 million and $12 million were included in SG&A for the second quarter and first six months of fiscal 2022, as compared to $101 million and $211 million for the comparable periods of the prior fiscal year.
Depreciation and Amortization
Depreciation expense was $165 million and $323 million for the second quarter and first six months of fiscal 2022, respectively. Depreciation expense decreased by $35 million and $55 million during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. The net decrease in depreciation expense for the second quarter and first six months of fiscal 2022 was primarily due to asset life adjustments in the prior year and a reduction in assets due to impairment of undeployed assets and asset retirements.
Amortization expense was $283 million and $547 million for the second quarter and first six months of fiscal 2022, respectively. Amortization expense decreased by $42 million and $92 million during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. The decrease was primarily due to a reduction in customer related intangibles related to the disposition of the HHS business at the beginning of the third quarter of fiscal 2021. See Note 4 – “Divestitures” for additional information.
Restructuring Costs
During fiscal 2022, management approved global cost savings initiatives designed to better align our workforce and facility structures. During the second quarter and first six months of fiscal 2022, restructuring costs, net of reversals, were $145 million and $212 million, respectively, as compared to $265 million and $337 million during the same periods of the prior fiscal year.
For an analysis of changes in our restructuring liabilities by restructuring plans, see Note 14 – “Restructuring Costs” to the financial statements.
Interest Expense and Interest Income
Interest expense was $61 million and $123 million for the second quarter and first six months of fiscal 2022, respectively. Interest expense decreased by $35 million and $79 million during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily due to a reduction in bonds and term loans, decreased amounts drawn on our revolving credit facility, and decreases to finance leases and asset financing.
Interest income was $16 million and $36 million for the second quarter and first six months of fiscal 2022, respectively. Interest income decreased by $9 million and $12 million during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. These decreases were primarily driven by lower income from our multicurrency cash pools and money market accounts.
Debt Extinguishment Costs
Debt extinguishment costs were $281 million and $309 million for the second quarter and first six months of fiscal 2022, respectively. Debt extinguishment costs for the second quarter of fiscal 2022 include costs to fully redeem our Euro-denominated term loan facility, 4.25% senior notes due fiscal 2025, 2.75% senior notes due fiscal 2025, 4.125% senior notes due fiscal 2026, 4.750% senior notes due fiscal 2028, and 7.45% senior notes due fiscal 2030.
Debt extinguishment costs for the first six months of fiscal 2022 also includes activity from the first quarter of fiscal 2022 consisting of full redemption of two series of 4.45% senior notes due fiscal 2023, partial redemption of 4.125% senior notes due fiscal 2026, and extinguishment of debt associated with asset financing. There were no debt extinguishment costs recorded during the same period in fiscal 2021.
Gain on Disposition of Businesses
During the first quarter of fiscal 2022, DXC sold its HPS business for $551 million which resulted in an estimated pre-tax gain on sale of $341 million, net of closing costs. Insignificant businesses were also sold during the first quarter of fiscal 2022 that resulted in a gain of $49 million. This was partially offset by $13 million in sales price adjustments related to prior year dispositions, which resulted from changes in projected closing net working capital.
Other Income, Net
Other income, net comprises non-service cost components of net periodic pension income, movement in foreign currency exchange rates on our foreign currency denominated assets and liabilities and the related economic hedges, equity earnings of unconsolidated affiliates and other miscellaneous gains and losses.
Other income was $102 million and $205 million for the second quarter and first six months of fiscal 2022, respectively, as compared to $103 million and $191 million during the same periods of the prior fiscal year. Other income decreased $(1) million during the second quarter of fiscal 2022 and increased $14 million during the first six months of fiscal 2022 as compared to the same periods of the prior fiscal year. The increase during the first six months of fiscal 2022 was primarily due to net gains on sales of operating and non-operating assets partially offset by lower non-service components of net periodic pension income.
Taxes
Our effective tax rate (“ETR”) was 24.6% and 19.6% for the three months ended September 30, 2021 and September 30, 2020, respectively, and 46.0% and 16.2% for the six months ended September 30, 2021 and September 30, 2020, respectively. For the three months ended September 30, 2021, the primary drivers of the ETR were the global mix of income and a decrease in unrecognized tax benefits due to income tax audit settlements and statute expirations. For the six months ended September 30, 2021, the primary drivers of the ETR were the global mix of income, gain on sale of HPS business, tax rate changes in non-U.S. jurisdictions and a decrease in unrecognized tax benefits due to income tax audit settlements and statute expirations. For the three and six months ended September 30, 2020, the primary drivers of the ETR were the global mix of income, foreign tax credits and adjustment of the prior tax provisions due to the filing of tax returns in the U.S. and the non-U.S. jurisdictions.
The United States Congress is currently working to enact a tax reform bill, which would result in significant changes to the U.S. tax system. We expect that if a bill is enacted, it could have a material impact on our Consolidated Financial Statements in future periods. We continue to monitor developments and assess the impact to DXC.
Earnings (Loss) Per Share
Diluted EPS for the second quarter and first six months of fiscal 2022 was $(0.74) and $0.35, respectively. Diluted earnings per share increased by $0.22 and $2.12 during the second quarter and first six months of fiscal 2022, respectively, as compared to the same periods of the prior fiscal year. Increases in diluted EPS were due to net income increases of $59 million and $540 million during the second quarter and first six months of fiscal 2022, respectively, over the same periods in the prior fiscal year.
Diluted EPS for the second quarter of fiscal 2022 includes $0.43 per share of restructuring costs, $0.01 per share of transaction, separation and integration-related costs, $0.33 per share of amortization of acquired intangible assets, $0.03 per share of impairment losses, and $0.84 per share of debt extinguishment costs.
Diluted EPS for the first six months of fiscal 2022 includes $0.65 per share of restructuring costs, $0.03 per share of transaction, separation and integration-related costs, $0.65 per share of amortization of acquired intangible assets, $(0.99) per share of net gains on dispositions, $0.03 per share of impairment losses, $0.91 per share of debt extinguishment costs, and $0.11 per share of tax adjustments relating to the net revaluation of deferred taxes resulting from changes in non-US jurisdiction tax rates.
Non-GAAP Financial Measures
We present non-GAAP financial measures of performance which are derived from the statements of operations of DXC. These non-GAAP financial measures include earnings before interest and taxes (“EBIT”), adjusted EBIT, non-GAAP income before income taxes, non-GAAP net income, non-GAAP net income attributable to DXC common stockholders, and non-GAAP EPS, and constant currency revenues.
We believe EBIT, adjusted EBIT, non-GAAP income before income taxes, non-GAAP net income, non-GAAP net income attributable to DXC common stockholders, and non-GAAP EPS provide investors with useful supplemental information about our operating performance after excluding certain categories of expenses.
We believe constant currency revenues provides investors with useful supplemental information about our revenues after excluding the effect of currency exchange rate fluctuations for currencies other than U.S. dollars in the periods presented. See below for a description of the methodology we use to present constant currency revenues.
One category of expenses excluded from adjusted EBIT, non-GAAP income before tax, non-GAAP net income and non-GAAP EPS, incremental amortization of intangible assets acquired through business combinations, may result in a significant difference in period over period amortization expense on a GAAP basis. We exclude amortization of certain acquired intangible assets as these non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Although DXC management excludes amortization of acquired intangible assets primarily customer-related intangible assets, from its non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets were recorded as part of purchase accounting and support revenue generation. Any future transactions may result in a change to the acquired intangible asset balances and associated amortization expense.
Another category of expenses excluded from adjusted EBIT, non-GAAP income before tax, non-GAAP net income and non-GAAP EPS is impairment losses, which may result in a significant difference in period over period expense on a GAAP basis. We exclude impairment losses as these non-cash amounts, reflect generally an acceleration of what would be multiple periods of expense and do not expect to occur frequently. Further assets such as goodwill may be significantly impacted by market conditions outside of management’s control.
There are limitations to the use of the non-GAAP financial measures presented in this report. One of the limitations is that they do not reflect complete financial results. We compensate for this limitation by providing a reconciliation between our non-GAAP financial measures and the respective most directly comparable financial measure calculated and presented in accordance with GAAP. Additionally, other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes between companies. Selected references are made on a “constant currency basis” so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby providing comparisons of operating performance from period to period. Financial results on a “constant currency basis” are non-GAAP measures calculated by translating current period activity into U.S. dollars using the comparable prior period’s currency conversion rates. This approach is used for all results where the functional currency is not the U.S. dollar. Please see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Results of Operations—Fiscal 2022 Second Quarter Highlights.”
Certain non-GAAP financial measures and the respective most directly comparable financial measures calculated and presented in accordance with GAAP include:
(in millions)
| Three Months Ended September 30, 2021 | September 30, 2020 | Change | Percentage Change | |
|---|---|---|---|---|
| Loss before income taxes | $(248) | $(306) | $58 | (19.0)% |
| Non-GAAP income before income taxes | $301 | $212 | $89 | 42.0% |
| Net loss | $(187) | $(246) | $59 | (24.0)% |
| Adjusted EBIT | $346 | $283 | $63 | 22.3% |
(in millions)
| Six Months Ended September 30, 2021 | September 30, 2020 | Change | Percentage Change | |
|---|---|---|---|---|
| Income (loss) before income taxes | $176 | $(531) | $707 | NM(1) |
| Non-GAAP income before income taxes | $591 | $319 | $272 | 85.3% |
| Net income (loss) | $95 | $(445) | $540 | NM(1) |
| Adjusted EBIT | $678 | $473 | $205 | 43.3% |
(1) Calculation is not meaningful.
Reconciliation of Non-GAAP Financial Measures
Our non-GAAP adjustments include:
- Restructuring costs – includes costs, net of reversals, related to workforce and real estate optimization and other similar charges.
- Transaction, separation and integration-related (“TSI”) costs – includes costs related to integration, planning, financing and advisory fees and other similar charges associated with mergers, acquisitions, strategic investments, joint ventures, and dispositions and other similar transactions.(1)
- Amortization of acquired intangible assets – includes amortization of intangible assets acquired through business combinations.
- Gains and losses on dispositions – gains and losses related to dispositions of businesses, strategic assets and interests in less than wholly-owned entities.(2)
- Impairment losses – impairment losses on assets classified as long-term on the balance sheet.(3)
- Debt extinguishment costs – costs associated with early retirement, redemption, repayment or repurchase of debt and debt-like items including any breakage, make-whole premium, prepayment penalty or similar costs as well as solicitation and other legal and advisory expenses.(4)
- Pension and OPEB actuarial and settlement gains and losses – pension and OPEB actuarial mark to market adjustments and settlement gains and losses.
- Tax adjustments – discrete tax adjustments to impair or recognize certain deferred tax assets, adjustments for changes in tax legislation and the impact of merger and divestitures. Income tax expense of all other (non-discrete) non-GAAP adjustments is based on the difference in the GAAP annual effective tax rate (AETR) and overall non-GAAP provision (consistent with the GAAP methodology).(5)
(1) TSI-Related Costs include fees and other internal and external expenses associated with legal, accounting, consulting, due diligence, investment banking advisory, and other services, as well as financing fees, retention incentives, and resolution of transaction related claims in connection with, or resulting from, exploring or executing potential acquisitions, dispositions and strategic investments, whether or not announced or consummated.
The TSI-Related costs for the second quarter of fiscal 2022 include $2 million of costs to execute the strategic alternatives; ($2 million) credit to legal costs for Peraton Arbitration; and $3 million of costs incurred in connection with activities related to other acquisitions and divestitures.
The TSI-Related costs for the first six months of fiscal 2022 include $13 million of costs to execute the strategic alternatives; $4 million legal costs and ($14 million) credit towards Peraton Arbitration settlement, $4 million in expenses related to integration projects resulting from the HPES merger (including costs associated with continuing efforts to separate certain IT systems) and $5 million of costs incurred in connection with activities related to other acquisitions and divestitures.
(2) Gains and losses on dispositions for the first six months of fiscal 2022 include a $341 million gain on sale of the HPS business, gains of $19 million on other dispositions and ($13 million) of adjustments relating to the sale of the HHS business.
(3) Impairment losses on dispositions for the second quarter and first six months of fiscal 2022 includes a $10 million impairment charge of capitalized transition and transformation costs.
(4) Debt extinguishment costs adjustments for the second quarter of fiscal 2022 include $1 million to fully redeem our Euro-denominated term loan facility, $41 million to fully redeem our 4.25% senior notes due fiscal 2025, $26 million to fully redeem our 2.75% senior notes due fiscal 2025, $55 million to fully redeem our 4.125% senior notes due fiscal 2026, $87 million to fully redeem our 4.750% senior notes due fiscal 2028, and $71 million to fully redeem our 7.45% senior notes due fiscal 2030.
In addition to the above, debt extinguishment costs adjustments for the first six months of fiscal 2022 reflects activity from the first quarter of fiscal 2022, including $18 million to fully redeem two series of our 4.45% senior notes due fiscal 2023, $3 million to partially redeem our 4.125% senior notes due fiscal 2026, and $7 million of debt associated with asset financing.
(5) Tax adjustment for the first six months of fiscal 2022 reflects net revaluation of deferred taxes resulting from changes in non-US jurisdiction tax rates.
A reconciliation of reported results to non-GAAP results is as follows:
(in millions, except per-share amounts)
| Three Months Ended September 30, 2021 As Reported | Restructuring Costs | Transaction, Separation and Integration-Related Costs | Amortization of Acquired Intangible Assets | Impairment Losses | Debt Extinguishment Costs | Non-GAAP Results | |
|---|---|---|---|---|---|---|---|
| (Loss) income before income taxes | $(248) | $145 | $3 | $110 | $10 | $281 | $301 |
| Income tax (benefit) expense | (61) | 34 | 1 | 26 | 2 | 66 | 68 |
| Net (loss) income | (187) | 111 | 2 | 84 | 8 | 215 | 233 |
| Less: net income attributable to non-controlling interest, net of tax | 1 | — | — | — | — | — | 1 |
| Net (loss) income attributable to DXC common stockholders | $(188) | $111 | $2 | $84 | $8 | $215 | $232 |
| Effective Tax Rate | 24.6% | 22.6% | |||||
| Basic EPS | $(0.74) | $0.44 | $0.01 | $0.33 | $0.03 | $0.85 | $0.92 |
| Diluted EPS | $(0.74) | $0.43 | $0.01 | $0.33 | $0.03 | $0.84 | $0.90 |
| Weighted average common shares outstanding for: | |||||||
| Basic EPS | 252.40 | 252.40 | 252.40 | 252.40 | 252.40 | 252.40 | 252.40 |
| Diluted EPS | 252.40 | 257.20 | 257.20 | 257.20 | 257.20 | 257.20 | 257.20 |
(in millions, except per-share amounts)
| Six Months Ended September 30, 2021 As Reported | Restructuring Costs | Transaction, Separation and Integration-Related Costs | Amortization of Acquired Intangible Assets | Gains and Losses on Dispositions | Impairment Losses | Debt Extinguishment Costs | Tax Adjustment | Non-GAAP Results | |
|---|---|---|---|---|---|---|---|---|---|
| Income before income taxes | $176 | $212 | $12 | $219 | $(347) | $10 | $309 | $— | $591 |
| Income tax expense | 81 | 44 | 5 | 50 | (91) | 2 | 73 | (28) | 136 |
| Net income | 95 | 168 | 7 | 169 | (256) | 8 | 236 | 28 | 455 |
| Less: net income attributable to non-controlling interest, net of tax | 5 | — | — | — | — | — | — | — | 5 |
| Net income attributable to DXC common stockholders | $90 | $168 | $7 | $169 | $(256) | $8 | $236 | $28 | $450 |
| Effective Tax Rate | 46.0% | 23.0% | |||||||
| Basic EPS | $0.35 | $0.66 | $0.03 | $0.67 | $(1.01) | $0.03 | $0.93 | $0.11 | $1.77 |
| Diluted EPS | $0.35 | $0.65 | $0.03 | $0.65 | $(0.99) | $0.03 | $0.91 | $0.11 | $1.74 |
| Weighted average common shares outstanding for: | |||||||||
| Basic EPS | 253.53 | 253.53 | 253.53 | 253.53 | 253.53 | 253.53 | 253.53 | 253.53 | 253.53 |
| Diluted EPS | 258.90 | 258.90 | 258.90 | 258.90 | 258.90 | 258.90 | 258.90 | 258.90 | 258.90 |
58
(in millions, except per-share amounts)
| Three Months Ended September 30, 2020 As Reported | Restructuring Costs | Transaction, Separation and Integration-Related Costs | Amortization of Acquired Intangible Assets | Tax Adjustment | Non-GAAP Results | |
|---|---|---|---|---|---|---|
| (Loss) income before income taxes | $(306) | $265 | $101 | $152 | — | $212 |
| Income tax (benefit) expense | (60) | 52 | 26 | 35 | (2) | 51 |
| Net (loss) income | (246) | 213 | 75 | 117 | 2 | 161 |
| Less: net (loss) attributable to non-controlling interest, net of tax | (2) | — | — | — | — | (2) |
| Net (loss) income attributable to DXC common stockholders | $(244) | $213 | $75 | $117 | $2 | $163 |
| Effective Tax Rate | 19.6% | 24.1% | ||||
| Basic EPS | $(0.96) | $0.84 | $0.30 | $0.46 | $0.01 | $0.64 |
| Diluted EPS | $(0.96) | $0.83 | $0.29 | $0.46 | $0.01 | $0.64 |
| Weighted average common shares outstanding for: | ||||||
| Basic EPS | 254.13 | 254.13 | 254.13 | 254.13 | 254.13 | 254.13 |
| Diluted EPS | 254.13 | 255.18 | 255.18 | 255.18 | 255.18 | 255.18 |
(in millions, except per-share amounts)
| Six Months Ended September 30, 2020 As Reported | Restructuring Costs | Transaction, Separation and Integration-Related Costs | Amortization of Acquired Intangible Assets | Pension and OPEB Actuarial and Settlement Losses | Tax Adjustment | Non-GAAP Results | |
|---|---|---|---|---|---|---|---|
| (Loss) income before income taxes | $(531) | $337 | $211 | $300 | $2 | — | $319 |
| Income tax (benefit) expense | (86) | 64 | 54 | 69 | — | (2) | 99 |
| Net (loss) income | (445) | 273 | 157 | 231 | 2 | 2 | 220 |
| Less: net income attributable to non-controlling interest, net of tax | 4 | — | — | — | — | — | 4 |
| Net (loss) income attributable to DXC common stockholders | $(449) | $273 | $157 | $231 | $2 | $2 | $216 |
| Effective Tax Rate | 16.2% | 31.0% | |||||
| Basic EPS | $(1.77) | $1.08 | $0.62 | $0.91 | $0.01 | $0.01 | $0.85 |
| Diluted EPS | $(1.77) | $1.07 | $0.62 | $0.91 | $0.01 | $0.01 | $0.85 |
| Weighted average common shares outstanding for: | |||||||
| Basic EPS | 253.88 | 253.88 | 253.88 | 253.88 | 253.88 | 253.88 | 253.88 |
| Diluted EPS | 253.88 | 254.76 | 254.76 | 254.76 | 254.76 | 254.76 | 254.76 |
59
Reconciliations of net income to adjusted EBIT are as follows:
(in millions)
| Three Months Ended September 30, 2021 | September 30, 2020 | Six Months Ended September 30, 2021 | September 30, 2020 | |
|---|---|---|---|---|
| Net (loss) income | $(187) | $(246) | $95 | $(445) |
| Income tax (benefit) expense | (61) | (60) | 81 | (86) |
| Interest income | (16) | (25) | (36) | (48) |
| Interest expense | 61 | 96 | 123 | 202 |
| EBIT | (203) | (235) | 263 | (377) |
| Restructuring costs | 145 | 265 | 212 | 337 |
| Transaction, separation and integration-related costs | 3 | 101 | 12 | 211 |
| Amortization of acquired intangible assets | 110 | 152 | 219 | 300 |
| (Gains) and losses on dispositions | — | — | (347) | — |
| Impairment losses | 10 | — | 10 | — |
| Debt extinguishment costs | 281 | — | 309 | — |
| Pension and OPEB actuarial and settlement losses | — | — | — | 2 |
| Adjusted EBIT | $346 | $283 | $678 | $473 |
60
Liquidity and Capital Resources
Cash and Cash Equivalents and Cash Flows
As of September 30, 2021, our cash and cash equivalents (“cash”) were $2.7 billion, of which $1.2 billion was held outside of the U.S. As of March 31, 2021, our cash was $3.0 billion, of which $1.3 billion was held outside of the U.S. We maintain various multi-currency, multi-entity, cross-border, physical and notional cash pool arrangements with various counterparties to manage liquidity efficiently that enable participating subsidiaries to draw on the Company’s pooled resources to meet liquidity needs.
A significant portion of the cash held by our foreign subsidiaries is not expected to be impacted by U.S. federal income tax upon repatriation. However, a portion of this cash may still be subject to foreign and U.S. state income tax consequences upon future remittance. Therefore, if additional funds held outside the U.S. are needed for our operations in the U.S., we plan to repatriate the funds not designated as indefinitely reinvested.
We have $0.1 billion in cash held by foreign subsidiaries used for local operations that is subject to country-specific limitations which may restrict or result in increased costs in the repatriation of these funds. In addition, other practical considerations may limit our use of consolidated cash. This includes cash of $0.7 billion held in a German financial services subsidiary subject to regulatory requirements, and $0.1 billion held by majority owned consolidated subsidiaries where third-parties or public shareholders hold minority interests.
The following table summarizes our cash flow activity:
(in millions)
| Six Months Ended September 30, 2021 | September 30, 2020 | Change | |
|---|---|---|---|
| Net cash provided by operating activities | $534 | $591 | $(57) |
| Net cash provided by (used in) investing activities | 199 | (234) | 433 |
| Net cash used in financing activities | (1,063) | (963) | (100) |
| Effect of exchange rate changes on cash and cash equivalents | (2) | 9 | (11) |
| Cash classified within current assets held for sale | 63 | (3) | 66 |
| Net decrease in cash and cash equivalents | $(269) | $(600) | $331 |
| Cash and cash equivalents at beginning of year | 2,968 | 3,679 | |
| Cash and cash equivalents at the end of period | $2,699 | $3,079 |
Operating cash flow
Net cash provided by operating activities during the first six months of fiscal 2022 was $534 million as compared to $591 million during the comparable period of the prior fiscal year. The decrease of $57 million was primarily due to a $210 million unfavorable change in working capital due to higher working capital outflows during the first six months of fiscal 2022 partially offset by an increase in net income, net of adjustments of $153 million.
The following table contains certain key working capital metrics:
| Six Months Ended September 30, 2021 | September 30, 2020 | ||
|---|---|---|---|
| Days of sales outstanding in accounts receivable | 67 | 67 | |
| Days of purchases outstanding in accounts payable | (38) | (58) | |
| Cash conversion cycle | 29 | — | 9 |
61
Investing cash flow
Net cash provided by (used in) investing activities during the first six months of fiscal 2022 was $199 million as compared to $(234) million during the comparable period of the prior fiscal year. The increase in net cash provided by investing activities of $433 million was primarily due to business dispositions of $513 million, an increase in proceeds from sale of assets of $79 million, and proceeds from short-term investing of $24 million. This was partially offset by a decrease in cash collections related to deferred purchase price receivables of $159 million and an increase in capital expenditures of $40 million.
Financing cash flow
Net cash used in financing activities during the first six months of fiscal 2022 was $1,063 million as compared to $963 million during the comparable period of the prior fiscal year. The $100 million increase in cash used was primarily due to a decrease in commercial paper borrowings, net of repayments of $298 million, an increase in payments on capital leases and borrowings for asset financing of $184 million, share repurchases of $150 million, and payments for debt extinguishment costs of $344 million. This was partially offset by an increase in borrowings on long term debt, net of repayments of $549 million and the lines of credit repayments, net of borrowings of $250 million and dividend payments of $53 million incurred only in the comparable period of fiscal 2021.
Capital Resources
See Note 21 – “Commitments and Contingencies” for a discussion of the general purpose of guarantees and commitments. The anticipated sources of funds to fulfill such commitments are listed below and under the “Liquidity” subheading.
The following table summarizes our total debt:
(in millions)
| As of September 30, 2021 | March 31, 2021 | |
|---|---|---|
| Short-term debt and current maturities of long-term debt | $745 | $1,167 |
| Long-term debt, net of current maturities | 4,363 | 4,345 |
| Total debt | $5,108 | $5,512 |
The $0.4 billion decrease in total debt during the first six months of fiscal 2022 was primarily attributed to the retirement of all the remaining $319 million of the 4.45% senior notes due fiscal 2023 using the proceeds from the sale of our HPS Business, and the repurchase of the $33 million of the 4.125% senior notes due fiscal 2026 during the first quarter of fiscal 2022. Approximately $300 million of finance lease liabilities and borrowings for assets acquired under long-term financing were also repaid during the second quarter of fiscal 2022 using the proceeds from the divestitures of other businesses and existing cash on hand. The decrease was partially offset by the issuance of Euro and U.S. Dollar Senior Notes of which proceeds were used to repay term loans and senior notes as discussed below.
Euro Senior Notes Issuance
During the second quarter of fiscal 2022, we issued (i) €750 million aggregate principal amount of our 0.450% senior notes due fiscal 2028 and (ii) €600 million aggregate principal amount of our 0.950% senior notes due fiscal 2032 (collectively, the “Euro Notes”). The proceeds from the Euro Notes were applied principally to the repayment in full of the €400 million aggregate principal amount of outstanding borrowings under our Euro-denominated term loan facility, the repayment of our U.S. dollar-denominated 4.25% senior notes due fiscal 2025 and the repayment of our Sterling-denominated 2.75% senior notes due fiscal 2025.
U.S. Dollar Senior Notes Issuance
During the second quarter of fiscal 2022, we issued (i) $700 million aggregate principal amount of our 1.80% senior notes due fiscal 2027, and (ii) $650 million aggregate principal amount of our 2.375% senior notes due fiscal 2029 (collectively, the “USD Notes”). The proceeds from the USD Notes were used for the repayment of our remaining 4.125% senior notes due fiscal 2026, our 4.750% senior notes due fiscal 2028 and our 7.45% senior notes due fiscal 2030.
We were in compliance with all financial covenants associated with our borrowings as of September 30, 2021 and September 30, 2020.
Our credit ratings are as follows:
| Rating Agency Fitch Moody’s | Long Term Ratings BBB Baa2 | Short Term Ratings F-2 P-2 | Outlook Stable Stable |
|---|---|---|---|
| S&P | BBB- | - | Stable |
Liquidity
We expect our existing cash and cash equivalents, together with cash generated from operations, will be sufficient to meet our normal operating requirements for the next 12 months. We expect to continue using cash generated by operations as a primary source of liquidity; however, should we require funds greater than that generated from our operations to fund discretionary investment activities, such as business acquisitions, we have the ability to raise capital through borrowing under our revolving credit facility, issuance of capital market debt instruments such as commercial paper, term loans, and bonds. In addition, we currently utilize, and will further utilize our cross-currency cash pool for liquidity needs. However, there is no guarantee that we will be able to obtain debt financing, if required, on terms and conditions acceptable to us, if at all, in the future.
Our exposure to operational liquidity risk is primarily from long-term contracts which require significant investment of cash during the initial phases of the contracts. The recovery of these investments is over the life of the contracts and is dependent upon our performance as well as customer acceptance.
The following table summarizes our total liquidity:
(in millions)
| As of September 30, 2021 | |
|---|---|
| Cash and cash equivalents | $2,699 |
| Available borrowings under our revolving credit facility | 4,000 |
| Total liquidity | $6,699 |
In November 2021, subsequent to the end of the second quarter of fiscal 2022, we amended our revolving credit facility to among other things, decrease available borrowings from $4.0 billion to $3.0 billion.
Share Repurchases
During the first quarter of fiscal 2018, our Board of Directors authorized the repurchase of up to $2.0 billion of our common stock and during the third quarter of fiscal 2019, our Board of Directors approved an incremental $2.0 billion share repurchase. This program became effective on April 3, 2017 with no end date established. During the six months ended September 30, 2021, we repurchased 3,862,212 shares of our common stock at an aggregate cost of $150 million. See Note 17 – “Stockholders’ Equity” to the financial statements.
Dividends
To maintain our financial flexibility, we continue to suspend payment of quarterly dividends for fiscal 2022.
Off-Balance Sheet Arrangements
In the normal course of business, we are party to arrangements that include guarantees, the receivables securitization facility and certain other financial instruments with off-balance sheet risk, such as letters of credit and surety bonds. We also use performance letters of credit to support various risk management insurance policies. No liabilities related to these arrangements are reflected in our condensed consolidated balance sheets. There have been no material changes to our off-balance-sheet arrangements reported under Part II, Item 7 of our Annual Report on Form 10-K other than as disclosed below and in Note 6 – “Receivables” and Note 21 – “Commitments and Contingencies” to the financial statements in this Quarterly Report on Form 10-Q.
Contractual Obligations
The transactions below represent material changes to our contractual obligations since March 31, 2021.
Debt retirements and repayments:
- Retirement of the remaining $319 million in two series of 4.45% senior notes due fiscal 2023
- Repayment of the remaining aggregate principal amount of the Euro-denominated €400 million in term loan facility due fiscal 2023-2024
- Repayment of the remaining aggregate principal amount of $500 million in 4.25% senior notes due fiscal 2025
- Repayment of the remaining aggregate principal amount of the Sterling-denominated £250 million in 2.75% senior notes due fiscal 2025
- Repayment of the remaining aggregate principal amount of $500 million in 4.125% senior notes due fiscal 2026
- Repayment of the remaining aggregate principal amount of $500 million in 4.75% senior notes due fiscal 2028
- Repayment of the remaining aggregate principal amount of $234 million in 7.45% senior notes due fiscal 2030
- Retirement and prepayment of certain capital leases and equipment related financing
Debt issuances:
- Issuance of (i) $700 million in aggregate principal amount of 1.80% senior notes due fiscal 2027 and (ii) $650 million in aggregate principal amount of 2.375% senior notes due fiscal 2029
- Issuance of (i) Euro-denominated €750 million in aggregate principal amount of 0.45% senior notes due fiscal 2028 and Euro-denominated €600 million in aggregate principal amount of 0.95% senior notes due fiscal 2032
For further information see “Contractual Obligations” in Item 7 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.
For our minimum purchase commitments as of September 30, 2021, in connection with our long-term purchase agreements with certain software, hardware, telecommunication, and other service providers, see Note 21 – “Commitments and Contingencies.”
Critical Accounting Policies and Estimates
The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities. These estimates may change in the future if underlying assumptions or factors change. Accordingly, actual results could differ materially from our estimates under different assumptions, judgments or conditions. We consider the following policies to be critical because of their complexity and the high degree of judgment involved in implementing them: revenue recognition, income taxes, business combinations, defined benefit plans and valuation of assets. We have discussed the selection of our critical accounting policies and the effect of estimates with the audit committee of our board of directors. During the three months ended September 30, 2021, there were no changes to our critical accounting policies and estimates from those described in our fiscal 2021 Annual Report on Form 10-K except as mentioned in Note 1 – “Summary of Significant Accounting Policies.”
Market risk
As filed, 317 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
For quantitative and qualitative disclosures about market risk affecting DXC, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021. Our exposure to market risk has not changed materially since March 31, 2021.
Controls and procedures
As filed, 6,500 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2021 because of the material weakness in our internal control over financial reporting described below.
Control Activities
As previously disclosed during the third quarter of fiscal 2020, Management concluded there was a material weakness in internal controls over financial reporting related to the design and implementation of effective control activities based on the criteria established in the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework. Management identified multiple deficiencies that constitute a material weakness in the aggregate related to the establishment and timely reassessment of policies and procedures for complex transactions and processes and the related impacts for control activities.
As a result, we have concluded that there is a reasonable possibility that a material misstatement to our Condensed Consolidated Financial Statements would not be prevented or detected on a timely basis and therefore we concluded that the aggregation of these deficiencies represents a material weakness in our internal control over financial reporting as of September 30, 2021.
Notwithstanding the identified material weakness, management believes that the Condensed Consolidated Financial Statements and related financial information included in this 10-Q fairly present, in all material respects, our balance sheets, statements of operations, comprehensive (loss) income and cash flows as of and for the periods presented.
Remediation Plan
Management has taken and continues to take significant and comprehensive actions to remediate the material weakness. With the addition of new operations and finance leadership working in concert with the Audit Committee, Management assessed the root cause of the multiple deficiencies that aggregated to the material weakness.
The Audit Committee has been fully engaged and supportive of management’s efforts to remediate the Material Weakness. Beginning in the fourth quarter of fiscal 2020, the Audit Committee has received a remediation report at each regularly held meeting and had additional informal meetings specifically to review progress on the remediation. Participants have included the Chief Executive Officer, Chief Financial Officer, Corporate Controller, SOX Leader and Internal Audit to answer questions and take feedback from the Committee.
The following activities are designed as part of this remediation plan to (1) address the material weakness in the control activities component of the COSO framework and (2) enhance and improve our control activities and processes:
Actions to remediate the material weakness in the controls activities component of COSO:
- We appointed a new Chief Financial Officer during the third quarter of fiscal 2021 with previous experience as a Chief Accounting Officer and substantial experience leading a finance organization through transformation including remediating material weaknesses. Our Chief Financial Officer is leading our remediation efforts and is focused on driving change in our finance organization, control environment and culture.
- We appointed a new Corporate Controller and Principal Accounting Officer during the first quarter of fiscal 2022 with previous experience as a Corporate Controller and Chief Accounting Officer remediating material weaknesses.
- We evaluated our finance organization and have and will augment our finance team with additional professionals with the appropriate levels of accounting, controls, finance oversight and tax experience.
- We hired a dedicated team of controls and process experts to standardize our processes and focus our key controls to address material risks.
- We have increased communication and training to employees regarding internal control over financial reporting and disclosure controls and procedures.
- We have designed and implemented an enterprise wide process to timely identify, track and appropriately resolve and conclude on complex transactions and disclosures.
Additional enhancements to improve our control activities and processes:
- We have enhanced our financial cadence and discipline including increased reviews of the underlying performance of the business and related balance sheet accounts.
- We are enhancing key enterprise controls including financial operations reviews, working capital reviews, balance sheet reviews and assessment and monitoring of non-routine accounting transactions.
- We have assessed relevant policies focusing on ownership and accountability and reviewed and implemented changes to thresholds to focus on risk.
- We are refining the financial close process so it executes with the appropriate cadence and rigor to reduce the length of time it takes to close.
- We are standardizing processes and rationalizing and strengthening controls to mitigate significant risk, enhance control owner accountability and transparency to address deficiencies in a holistic and timely manner.
These additional remediation efforts have begun and are expected to be completed in the subsequent quarters. After management’s remediation efforts are complete, subsequent testing will be required to conclude that a material weakness no longer exists. Our goal is to have enhanced control policies, procedures, and processes in place as promptly as practicable, however, we are not in a position to complete our remediation plan and concluded that our internal control over financial reporting is not designed or operating effectively as of the quarter ended September 30, 2021.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the three months ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 1,171 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our operations and financial results are subject to various risks and uncertainties, which may materially and adversely affect our business, financial condition, and results of operations, and the actual outcome of matters as to which forward-looking statements are made in this Quarterly Report on Form 10-Q. In such case, the trading price for DXC common stock could decline, and you could lose all or part of your investment. Past performance may not be a reliable indicator of future financial performance and historical trends should not be used to anticipate results or trends in future periods. Future performance and historical trends may be adversely affected by the aforementioned risks, and other variables and risks and uncertainties not currently known or that are currently expected to be immaterial may also materially and adversely affect our business, financial condition, and results of operations or the price of our common stock in the future. There have been no material changes in the three months ended September 30, 2021 to the risk factors described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $4.03bn | us-gaap:Revenues |
| Revenue | 6 months2021-04-01 to 2021-09-30 | $8.17bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2021-07-01 to 2021-09-30 | $370.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-04-01 to 2021-09-30 | $753.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | $346.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-04-01 to 2021-09-30 | $678.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $61.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2021-04-01 to 2021-09-30 | $123.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-07-01 to 2021-09-30 | −$61.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-04-01 to 2021-09-30 | $81.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$188.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-04-01 to 2021-09-30 | $90.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | −$0.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-04-01 to 2021-09-30 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-07-01 to 2021-09-30 | −$0.74 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-04-01 to 2021-09-30 | $0.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-07-01 to 2021-09-30 | 252,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-04-01 to 2021-09-30 | 258,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-04-01 to 2021-09-30 | $534.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-04-01 to 2021-09-30 | $165.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2021-04-01 to 2021-09-30 | $0 | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2021-09-30 | $2.70bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $7.38bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $20.11bn | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $6.82bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $15.03bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $4.36bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-09-30 | $179.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2021-09-30 | $232.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-09-30 | $4.77bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001688568-21-000090. Last ingested by Listed: Oct 31, 2026, 02:14 ET. Listed shows no prices and gives no investment advice.